Company snapshot: Novo Nordisk
9 November 2010 News Archive
What's the secret of Danish diabetes specialist Novo Nordisk's success?
$100m of diabetes R&D in China
24 September 2012
Danish drug maker Novo Nordisk has announced plans to invest $100 million (£62 million) in its R&D site in Beijing, China. The move will create 130–200 new research jobs.
Novo Nordisk was one of the first big pharma companies to establish at R&D outpost in China, making the move in 1997. The company currently employs 130 researchers at the Beijing site, part of its 3000 strong workforce across all business areas in the country.
The company specialises in insulin products for the treatment of diabetes.
Most Read
An end to chasing molecules that were never there?
12 June 2013 Research
Simple method for identifying incorrect structures of organic molecules due to NMR misassignments
Bacterium breaks down grass for biofuel
13 June 2013 Research
Microbe that anaerobically degrades plant biomass could help bring down the cost of biofuels
Most Commented
New gel to repair damaged discs
31 August 2012 Research
Microgel jab might one day eliminate the need for spinal surgery
Forget tax credits, fund applied research
17 June 2013 News and Analysis
Thinktank says hundreds of millions of pounds of tax breaks are going to city business firms and would be better spent elsewh...